肿瘤药物的成本：药学视角，第二部分。
The Cost of Oncology Drugs: A Pharmacy Perspective, Part 2.
作者信息
Dahl Brian J
机构信息
is a clinical pharmacy specialist in oncology and director of the Oncology Pharmacy Program at the VA San Diego Healthcare System in California.
出版信息
Fed Pract. 2016 Jul;33(7):35-39.
Abstract
Guidance documents, the Pharmacy Benefits Management Services, and the VA National Formulary help clinicians and pharmacists decide whether to administer high-cost cancer treatments.
摘要
指导文件、药房福利管理服务以及退伍军人事务部国家处方集有助于临床医生和药剂师决定是否给予高成本的癌症治疗。
相似文献
1
The Cost of Oncology Drugs: A Pharmacy Perspective, Part 2.肿瘤药物的成本：药学视角，第二部分。
Fed Pract. 2016 Jul;33(7):35-39.
2
Pharmacy Benefits Management in the Veterans Health Administration Revisited: A Decade of Advancements, 2004-2014.再次审视退伍军人健康管理局的药品福利管理：2004-2014 年的十年进展。
J Manag Care Spec Pharm. 2016 Sep;22(9):1058-63. doi: 10.18553/jmcp.2016.22.9.1058.
3
Variation in Formulary Management Practices Within the Department of Veterans Affairs Health Care System.退伍军人事务部医疗保健系统内处方管理实践的差异。
J Manag Care Spec Pharm. 2016 Feb;22(2):114-20. doi: 10.18553/jmcp.2016.14251. Epub 2015 Dec 14.
4
Formulary & benefit and real-time pharmacy Benefit: Electronic standards delivering value to prescribers and pharmacists.处方集和福利及实时药房福利：电子标准为开处方者和药剂师提供价值。
J Am Pharm Assoc (2003). 2023 May-Jun;63(3):725-730. doi: 10.1016/j.japh.2023.01.016. Epub 2023 Feb 4.
5
Controlling the Cost of Oncology Drugs Within the VA: A National Perspective.控制退伍军人事务部内部的肿瘤药物成本：全国视角
Fed Pract. 2015 Jan;32(Suppl 1):16S-20S.
6
Analysis of nonformulary use of PPIs and excess drug cost in a Veterans Affairs population.退伍军人事务部人群中质子泵抑制剂非处方使用及药物成本过高的分析。
J Manag Care Pharm. 2012 Jan-Feb;18(1):63-7. doi: 10.18553/jmcp.2012.18.1.63.
7
Pharmaceutical services in the Department of Veterans Affairs.退伍军人事务部的药学服务
Am J Health Syst Pharm. 1997 Apr 1;54(7):761-5. doi: 10.1093/ajhp/54.7.761.
8
Evaluation of pharmacy services in emergency departments of Veterans Affairs Medical Centers.退伍军人事务医疗中心急诊科药学服务评估
Am J Health Syst Pharm. 2015 Sep 1;72(17 Suppl 2):S110-4. doi: 10.2146/sp150019.
9
Perceptions and expectations of health care providers towards clinical pharmacy services at a tertiary cancer centre in Qatar.卡塔尔一家三级癌症中心的医疗服务提供者对临床药学服务的认知与期望。
J Oncol Pharm Pract. 2020 Jul;26(5):1086-1096. doi: 10.1177/1078155219882076. Epub 2019 Nov 13.
10
Pharmacy benefits management in the Veterans Health Administration: 1995 to 2003.退伍军人健康管理局的药房效益管理：1995年至2003年
Am J Manag Care. 2005 Feb;11(2):104-12.
本文引用的文献
1
Controlling the Cost of Oncology Drugs Within the VA: A National Perspective.控制退伍军人事务部内部的肿瘤药物成本：全国视角
Fed Pract. 2015 Jan;32(Suppl 1):16S-20S.
2
Necitumumab in Metastatic Squamous Cell Lung Cancer: Establishing a Value-Based Cost.尼妥珠单抗治疗转移性鳞状非小细胞肺癌：建立基于价值的成本核算。
JAMA Oncol. 2015 Dec;1(9):1293-300. doi: 10.1001/jamaoncol.2015.3316.
3
Necitumumab plus gemcitabine and cisplatin versus gemcitabine and cisplatin alone as first-line therapy in patients with stage IV squamous non-small-cell lung cancer (SQUIRE): an open-label, randomised, controlled phase 3 trial.耐昔妥珠单抗联合吉西他滨和顺铂与吉西他滨和顺铂单药一线治疗局部晚期或转移性鳞状非小细胞肺癌患者（SQUIRE）：一项开放标签、随机、对照的 3 期临床试验。
Lancet Oncol. 2015 Jul;16(7):763-74. doi: 10.1016/S1470-2045(15)00021-2. Epub 2015 Jun 1.
4
High cancer drug prices in the United States: reasons and proposed solutions.美国抗癌药物价格高昂：原因及建议解决方案
J Oncol Pract. 2014 Jul;10(4):e208-11. doi: 10.1200/JOP.2013.001351. Epub 2014 May 6.
5
In a survey, marked inconsistency in how oncologists judged value of high-cost cancer drugs in relation to gains in survival.在一项调查中，肿瘤学家在判断高成本癌症药物的价值与生存获益方面存在显著的不一致。
Health Aff (Millwood). 2012 Apr;31(4):709-17. doi: 10.1377/hlthaff.2011.0251.
6
How cancer patients value hope and the implications for cost-effectiveness assessments of high-cost cancer therapies.癌症患者如何看待希望，以及对高价癌症疗法成本效益评估的影响。
Health Aff (Millwood). 2012 Apr;31(4):676-82. doi: 10.1377/hlthaff.2011.1300.
7
Limits on Medicare's ability to control rising spending on cancer drugs.医疗保险在控制癌症药物支出不断上涨方面的能力限制。
N Engl J Med. 2009 Feb 5;360(6):626-33. doi: 10.1056/NEJMhpr0807774. Epub 2009 Jan 27.
8
Comparison of quality of care for patients in the Veterans Health Administration and patients in a national sample.退伍军人健康管理局患者与全国样本患者的医疗质量比较。
Ann Intern Med. 2004 Dec 21;141(12):938-45. doi: 10.7326/0003-4819-141-12-200412210-00010.
Zotero 插件